Back to search

Article

Unveiling the Immunological Terrain of Pancreatic Ductal Adenocarcinoma: Strategies to Prompt Immunotherapy from Mendelian Randomization

2024-03-21

Abstract excerpt

<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge in oncology, characterized by its immunosuppressive tumor microenvironment (TME) and resistance to immune checkpoint inhibitors (ICIs). This study leverages Mendelian randomization (MR) to elucidate the causal relationships between PDAC and a comprehensive array of immune cell traits, bacterial traits, inflammatory f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fea353d7-1cdb-59ca-9196-fd83ec2f98bc
DOI
10.21203/rs.3.rs-4000359/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unveiling the Immunological Terrain of Pancreatic Ductal Adenocarcinoma: Strategies to Prompt Immunotherapy from Mendelian RandomizationDOI 10.21203/rs.3.rs-4000359/v1
Select a neighboring publication to make it the new centre.